← FDA DRUG APPROVALS

FDA ANDA · ANDA070271

NALIDIXIC ACID

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA070271
TYPE
ANDA
ORIGINAL APPROVAL
1986-03-29
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

NALIDIXIC ACIDDiscontinued
NALIDIXIC ACID 500MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 10AP
1994-12-23Manufacturing (CMC) · Supplement 9AP
1994-10-11Manufacturing (CMC) · Supplement 8AP
1992-04-03Manufacturing (CMC) · Supplement 5AP
1992-04-03Manufacturing (CMC) · Supplement 7AP
1988-02-09Manufacturing (CMC) · Supplement 2AP
1986-03-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →